 | ||||||
| Ebola | ||||||
| NEWS | ||||||
| Scientists Developed New Technology for Diagnosing Immunity to Ebola A promising new approach to detect immunity to Ebola virus infection has been developed by researchers from i-sense in a collaboration between UCL and Imperial College London. The new approach uses lateral flow technology similar to that of a pregnancy test coupled with smartphones to provide a ...
| ||||||
| Ambitious global virome project could mark end of pandemic era Bats, called Lyle's flying foxes, hang from a tree in Cambodia. Bat viruses can spill over into humans, resulting in new emerging diseases. Credit: Kathy West/UC Davis One Health Institute. Rather than wait for viruses like Ebola, SARS and Zika to become outbreaks that force the world to react, a new ...
| ||||||
| A New Day? Fast, Inexpensive Human Genome Will Open Doors The small sequencing devices have been used previously to track the Ebola and Zika epidemics, but the human genome is many orders of magnitude larger than those bacterial and viral genomes, making this "a huge technical achievement," Benedict Paten, PhD, one of the coauthors of the article, ...
| ||||||
| Novavax (NVAX) Stock: Should You Buy The Dip? Novavax, Inc. NVAX Stock News Novavax, Inc. (NASDAQ: NVAX) isn't having the best of starts to the trading session in the pre-market hours this morning. In fact, the stock is trading in the red. However, given recent news surrounding the company, many are wondering if this is a dip worth buying. Today ...
| ||||||
| See more results | Edit this alert | ||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
Tidak ada komentar:
Posting Komentar